Compound ID | 3289
Synonym(s): XF73 | XF 73
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Membrane-active agent. Membrane-perturbing but non-lytic |
| Target Pathogen: | Active against methicillin-resistant and -susceptible Staphylococcus aureus |
| Institute where first reported: | Destiny Pharma Plc |
| Year first mentioned: | 2023 |
| Highest development stage: | Phase 2 (NCT03915470) |
| Development status: | Active (as of 2024) |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/135456186 |
| Guide to Pharmacology: | exeporfinium |
| Citations: |
|